Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/03/2012WO2012006525A3 Pkc activators and anticoagulant in regimen for treating stroke
05/03/2012WO2012006437A3 Polypeptides having antiviral activity and methods for use thereof
05/03/2012WO2012002762A3 Peptide for the treatment or prevention of allergic diseases
05/03/2012WO2011159865A3 Compositions and methods for using human ykl-40 to treat acute lung injury
05/03/2012WO2011144673A3 Long - acting formulations of insulins
05/03/2012WO2011133685A3 Nanoparticle targeting to ischemia for imaging and therapy
05/03/2012WO2011120903A3 A fast dissolving pharmaceutical composition
05/03/2012WO2011120013A3 Vista regulatory t cell mediator protein, vista binding agents and use thereof
05/03/2012WO2011110367A3 Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection
05/03/2012WO2011085957A3 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
05/03/2012WO2011041847A8 Chaperonin 10 variants
05/03/2012US20120110706 Modified bacillus thuringiensis cry21 proteins for nematode control
05/03/2012US20120110693 Targeting nucleic acids in mitochondria
05/03/2012US20120109106 Drug delivery system for accelerated subcutaneous absorption
05/03/2012US20120109044 Prevention of myocardial infraction induced ventricular expansion and remodeling
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108525 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/03/2012US20120108524 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
05/03/2012US20120108523 Disease-associated protein
05/03/2012US20120108522 Hdac inhibitors and hormone targeted drugs for the treatment of cancer
05/03/2012US20120108521 Immunostimulatory compositions and uses thereof
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120108519 Neo-tryptophan
05/03/2012US20120108518 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
05/03/2012US20120108517 Agents and methods for denervation
05/03/2012US20120108516 The use of midkine protein and the protein-containing medical device
05/03/2012US20120108515 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
05/03/2012US20120108514 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
05/03/2012US20120108513 Purification method for divalent cation binding proteins on anion exchange resin
05/03/2012US20120108512 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
05/03/2012US20120108511 Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
05/03/2012US20120108510 Methods of improving behavioral therapies
05/03/2012US20120108509 Artificial scab for use in an airway
05/03/2012US20120108508 Method for promoting secretion of glucagon-like peptide-1 by administering k-casein
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108506 Agent For Suppressing Postprandial Elevation Of Blood Insulin Concentration
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120108504 Leptin agonist and methods of use
05/03/2012US20120108503 Methods for treating type i diabetes with leptin and leptin agonists
05/03/2012US20120108502 Novel anti-parasitic compounds
05/03/2012US20120108501 Protease Inhibitors
05/03/2012US20120108500 Compositions and Methods for Modulating Immunodeficiency Virus Transcription
05/03/2012US20120108499 Peptoid compounds
05/03/2012US20120108498 Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase
05/03/2012US20120108497 Compositions for conferring tolerance to viral disease in social insects, and the use thereof
05/03/2012US20120108496 Short-chain peptides as parathyroid hormone (pth) receptor agonist
05/03/2012US20120108495 Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120108492 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
05/03/2012US20120107867 Glycopegylated erythropoietin
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107412 Use of cellular extracts for skin rejuvenation
05/03/2012US20120107410 Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
05/03/2012US20120107408 Pharmaceutical microparticles
05/03/2012US20120107407 Bone graft and biocomposite for prosthetic dentistry
05/03/2012US20120107394 Immuno-compatible hydrogel system
05/03/2012US20120107377 Particulate composition and pharmaceutical composition containing the same
05/03/2012US20120107374 Coenzyme q10-containing composition
05/03/2012US20120107372 Recombinant gelatins
05/03/2012US20120107371 Stimuli-responsive systems for controlled drug delivery
05/03/2012US20120107366 Block Copolymer Systems and Their Use in Medical Devices
05/03/2012US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
05/03/2012US20120107336 Modified defensins and their use
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107323 Kinase protein binding inhibitors
05/03/2012US20120107319 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
05/03/2012US20120107318 Methods of administering pif agonist peptides and uses thereof
05/03/2012US20120107317 Use of cytoplasmic c-myc for regulating immune responses
05/03/2012US20120107313 Mammalian receptor proteins; related reagents and methods
05/03/2012US20120107307 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
05/03/2012US20120107304 Combination therapy in treatment of oncological and fibrotic diseases
05/03/2012US20120107300 Cannabinoid Compositions and Methods
05/03/2012US20120107299 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107297 Method for therapeutic angiogenesis
05/03/2012US20120107296 Feed supplement
05/03/2012US20120107295 Methods and Compositions for Detecting Pancreatic Disease
05/03/2012US20120107278 Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
05/03/2012US20120107277 Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis
05/03/2012US20120107276 Anti-Arenaviral Compounds
05/03/2012US20120107275 Fused heterocyclic derivatives and methods of use
05/03/2012US20120107274 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120107272 Synthetic methods and derivatives of triphosphate oligonucleotides
05/03/2012US20120107271 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/03/2012US20120107270 Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of Cancer
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120107268 Lymph node-targeting nanoparticles
05/03/2012US20120107267 Interleukin-21 variants having antagonistic binding to the il-21 receptor
05/03/2012US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012US20120107241 Particles for Inhalation Having Sustained Release Properties
05/03/2012US20120107237 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
05/03/2012US20120104047 Composition for Relief of Insect Bites and Stings and Apparatus and Method for Its Delivery
05/03/2012DE102008062136B4 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk
05/03/2012CA2847197A1 Treatment for dupuytren's disease
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 3163